Related by context. All words. (Click for frequent words.) 73 kidney urologic 73 CYT# potent vascular disrupting 71 epithelial tumors 70 cisplatin resistant 69 demonstrated antitumor activity 69 immuno modulatory 69 Umbilical cord stem cells 69 tumor xenograft models 69 gastrointestinal stromal tumors GISTs 68 skeletal metastases 68 fusion enhancers 68 preclinical xenograft models 68 LHRH receptor positive 68 metastatic neuroendocrine tumors 68 small molecule activators 68 antimitotic 68 somatostatin 68 mda 7 68 oral squamous cell 68 neovascular diseases 67 molecular abnormalities 67 Ribavirin causes 67 neuroendocrine cancers 67 recurrent glioblastoma multiforme GBM 67 therapeutic monoclonal antibody 67 TÎ ² 4 67 KRAS mutant 67 allogeneic HSCT 67 papillary renal cell carcinoma 67 gastric carcinoma 67 humanised antibody 67 CTAP# Capsules 67 ANCA associated 67 humanized monoclonal antibodies 67 diagnostic biomarker 67 hPTH #-# 67 antibiotics antifungals 67 neuronal nicotinic receptor NNR 67 lymphomas leukemias 67 fluconazole resistant 67 histologic subtype 67 transgenic rats 67 novel VDA molecule 67 Colon polyps 66 orally administered inhibitor 66 pancreatic lung 66 receptor inhibitor 66 Gleevec resistant 66 5 HT2A serotonin 66 invasive lobular 66 metabolomic profiles 66 Evoltra ® 66 essential thrombocythemia ET 66 hypereosinophilic syndrome 66 L. pneumophila 66 psoriasis Crohn disease 66 isotypes 66 p# alpha [001] 66 Glioblastoma multiforme GBM 66 MCF7 66 hematopoietic cancers 66 tumor subtypes 66 osteosarcomas 66 Smac mimetic 66 Vidaza ® 66 SSc 66 pancreatic prostate 66 glucokinase activators 66 glioblastoma tumor 66 candidates Azedra TM 66 neuro degenerative disorders 66 enteroviral 66 gastro intestinal inflammation 66 hematopoietic malignancies 66 hypermethylated 66 Chronic lymphocytic leukemia CLL 66 relapsed MM 66 candida infections 66 PCA3 gene 66 chronic myeloid 66 NS#/#A protease 66 antisense inhibitors 66 Xanafide 66 alkylating 66 colorectal adenoma 66 radezolid 65 LymphoStat B belimumab 65 TTR amyloidosis 65 glial tumors 65 Systemic lupus erythematosus SLE 65 pathophysiological effects 65 beta islets 65 pancreatic adenocarcinoma 65 GRNOPC1 contains 65 biologic therapeutics 65 Factor Receptor 65 TRAIL R1 65 #beta HSD 1 65 TRIOLEX HE# APOPTONE HE# 65 flavopiridol 65 M.tb 65 Darapladib 65 molecular determinants 65 aneuploid cells 65 effector function 65 inverse agonist 65 small molecule agonists 65 pancreatic endocrine 65 immunotherapeutic approaches 65 PROSTVAC VF 65 delafloxacin 65 HCV protease inhibitors 65 prostate carcinoma 65 uricase 65 GVAX ® 65 relapsed leukemia 65 haematologic 65 alpha1 antitrypsin deficiency 65 immune modulating 65 Epothilones 65 nonnucleoside reverse transcriptase inhibitors 65 pediatric acute lymphoblastic 65 metastatic lymph nodes 65 Chronic lymphocytic leukemia 65 kinase inhibition 65 K ras mutations 65 Chlamydia trachomatis infection 65 immunological diseases 65 complement inhibitor eculizumab 65 Candida infection 65 hematological diseases 65 HER2 ErbB2 65 TOCOSOL Camptothecin 65 N. gonorrhoeae 65 leukemias lymphomas 65 corticosteroid dexamethasone 65 chemistry microbiology immunology 65 R Saizen R 65 Candida species 65 nanomolar 65 colorectal gastric 65 metabonomics 65 immune modulator 65 oncologic diseases 65 breast endometrial 65 Genentech Rituxan 65 pediatric malignancies 65 autoantibody positive 65 fibrosarcoma 65 immune dysregulation 65 riboflavin vitamin B2 65 ovarian breast 64 muscular dystrophy cystic fibrosis 64 isoform selective 64 rheumatoid arthritis lupus 64 XL# inhibits 64 discontinued Viread 64 HER2 overexpression 64 multiple sclerosis psoriasis 64 myelofibrosis polycythemia vera 64 A3 adenosine receptor 64 humanised monoclonal antibody 64 EGFR HER2 64 oral JAK1 64 Basal cell 64 unresectable tumors 64 gastric carcinomas 64 nucleoside analogs 64 xenograft models 64 nonsmall cell lung cancer 64 NRTI resistance 64 candidemia 64 human rhinovirus HRV 64 myeloproliferative diseases 64 basal cell carcinoma BCC 64 MCSP respectively 64 BCR ABL mutations 64 Ph + acute lymphoblastic 64 protein tyrosine phosphatase 1B 64 treating neuropathic pain 64 potently inhibit 64 immunocompetent 64 chromosomal mutations 64 receptor tyrosine kinase inhibitor 64 Tr DNA 64 cMET 64 anti angiogenic agents 64 Fas ligand 64 IL 1Ra 64 genus Plasmodium 64 cirrhosis liver failure 64 HGS ETR1 mapatumumab 64 induced mucositis 64 ovarian lung 64 Letairis ambrisentan 64 HER2 neu 64 HuCNS SC ® 64 multifactorial disease 64 IMiDs ® 64 TRIM5a 64 molecular biomarkers 64 cleavable linker 64 amyloid plaque formation 64 mGluR2 NAM 64 EGFR mutant 64 nucleotide analog 64 novel therapeutic antibodies 64 neovasculature 64 vitamin D analogs 64 JAK inhibitors 64 KRAS oncogene 64 MKC# MT 64 sirtuin activators 64 carcinoids 64 malignant lymphomas 64 gastric adenocarcinoma 64 acetonide FA 64 colorectal lung 64 hepatocellular carcinomas 64 acute GvHD 64 NMDA antagonists 64 liposomal formulation 64 Interferon beta 64 sarcomatoid 64 nutlin 3a 64 biologic pathway 64 obligate intracellular 64 T#I mutant 64 hepatoma 64 dysplastic lesions caused 64 mTOR inhibitors 64 prostate carcinomas 64 endosomal release 64 proteins peptides 64 oral leukoplakia 64 refractory chronic myeloid 64 anticoagulant reversing agent 64 fluoroquinolone resistance 64 TNF alpha antagonist 64 Squamous 64 oligodendrogliomas 64 refractory metastatic 64 Alimentary Tract 64 leukemia AML 64 cyclin dependent kinase inhibitor 64 Acute myelogenous leukemia 64 ADAMTS# 64 optical biosensors 64 Sudhir Agrawal D.Phil 64 indolent follicular non 64 replicon 64 lymphoid organs 64 accumulate preferentially 64 Combivir Kivexa 64 M2 subunit 64 thyroid carcinoma 64 tumorigenicity 64 malignant pheochromocytoma 64 inhibit metastasis 64 p# biomarker 64 AEG# 64 ESBA# 64 bladder ovarian 64 evaluating tivozanib 64 Haptoglobin 64 Alfacell proprietary ribonuclease 64 oral prodrug 64 herpes zoster shingles 64 simplex virus 64 polycythemia vera PV 64 Li Fraumeni 64 protein tyrosine phosphatases 64 TTR gene 64 plexiform neurofibromas 64 cystic fibrosis chronic pancreatitis 64 urothelial bladder cancer 64 NNRTI resistant virus 64 HNSCC 64 humanized therapeutic 64 HIV HCV coinfected 64 myeloproliferative neoplasms MPNs 64 multiplex assay 64 Lenocta 64 vinca alkaloid 64 lymphoid malignancies 63 PPAR gamma agonists 63 GSK3B 63 metastatic colorectal 63 splice variants 63 antitumour 63 Aplidin 63 TRAIL R2 63 thalidomide Thalomid 63 basal cell nevus syndrome 63 bexarotene 63 HER2 positive cancers 63 nasopharyngeal carcinoma 63 retroviral vectors 63 Trichophyton rubrum 63 immunodeficiency disorders 63 #T# L1 63 histone deacetylase HDAC 63 Cotara ® 63 LAB CGRP 63 refractory chronic lymphocytic 63 Anopheles gambiae mosquitoes 63 Radiographic findings 63 pancreatic islet 63 selectively inhibited 63 endocrine therapies 63 rheumatoid arthritis psoriatic arthritis 63 recurrent glioblastoma multiforme 63 ALK inhibitors 63 selective modulator 63 Treg cell 63 Leukemias 63 toenail onychomycosis 63 chlamydial 63 cytomegalovirus retinitis 63 carbohydrate polymers 63 VEGFR2 inhibitor 63 pancreas esophagus 63 squamous cell lung cancer 63 non mutated KRAS 63 TRAIL induced apoptosis 63 metastatic bladder 63 Alessandro Riva 63 ovarian carcinoma 63 intranasal delivery 63 anticancer therapeutics 63 ocular disorders 63 malignant prostate 63 lung ovary 63 invasive ductal 63 immunomodulation 63 targeted radiotherapeutic 63 Smac mimetics 63 inflammatory demyelinating 63 immunopathology 63 haematopoietic 63 methicillin susceptible Staphylococcus aureus 63 Upregulation 63 AAG geldanamycin analog 63 lung pancreatic 63 lymphoproliferative disorders 63 Chronic myeloid leukemia CML 63 Epstein Barr Virus EBV 63 hematologic cancers 63 potently inhibited 63 reverse transcriptase inhibitors 63 endometrial ovarian 63 HCV NS5B polymerase 63 mutated K ras 63 Mg Usa 63 antisense therapies 63 Glioblastoma Multiforme GBM 63 LRP5 63 metaglidasen 63 products MKC# PP 63 systemic fungal infections 63 Propionibacterium acnes 63 rifamycins 63 Leydig cell 63 Helicobacter pylori H. pylori 63 endothelin antagonist 63 telomerase inhibition 63 BRAF mutant 63 Histoplasma capsulatum 63 chronic HBV 63 Systemic lupus erythematosus 63 inflammatory autoimmune diseases 63 MEK inhibitors 63 Darinaparsin 63 prognostic markers 63 IMiDs R 63 clade B 63 lupus multiple sclerosis 63 lupus scleroderma 63 Tß4 63 severe malignant osteopetrosis 63 Leydig cells 63 Amgen Neulasta R 63 SETDB1 63 antagomirs 63 ocular inflammatory 63 Bordetella pertussis 63 chemopreventive agents 63 viral isolates 63 proliferative disorders 63 thetreatment 63 chemopreventive agent 63 dermatophytes 63 synovial cells 63 B7 H3 63 invasive candidiasis 63 cyclophilin inhibitors 63 candidate TNFerade biologic 63 Fludara ® 63 prostate pancreatic 63 nonalcoholic steatohepatitis NASH 63 ionotropic 63 proteasome inhibitor 63 Fibroblast Growth Factor Receptor 63 myelodysplastic myeloproliferative diseases 63 immunoregulation 63 proliferative diseases 63 arthritis RA 63 tryptase 63 Hodgkin lymphoma HL 63 relapsing remitting MS RRMS 63 histone deacetylase inhibitor 63 papillomaviruses 63 HIV coinfected 63 HER2 expression 63 cytomegalovirus CMV 63 deCODE BreastCancer 63 microtubule inhibitor 63 leukaemias 63 leukemia multiple myeloma 63 selective orally bioavailable 63 lenalidomide Revlimid R 63 rheumatoid arthritis multiple sclerosis 63 mouse testes 63 PPARg 63 PEGylated 63 nonhuman primate model 63 polyketides 63 CagA 63 histological subtypes 63 precursor lesions 63 renal cell carcinomas 63 retinoic acid receptor 63 CMV infections 63 systemic anaplastic large 63 PCNSL 63 gastrointestinal stromal 63 vinca alkaloids 63 CB2 receptor 63 nucleoside analogues 63 blood coagulation disorders 63 chronic eosinophilic leukemia 63 castration resistant hormone refractory 63 investigational monoclonal antibody 63 transthyretin TTR 63 pathological hallmark 63 XL# anticancer compounds 63 FGFs 63 targeting CD# 63 serine proteases 63 attach auristatin 63 C1 INH deficiency 63 Prolastin A1PI 63 dominantly inherited 63 Squalamine 63 imatinib Gleevec 63 colorectal neoplasms 63 TEL AML1 63 JAK2 enzyme 63 Prodarsan R 63 non nucleoside inhibitor 63 AML MDS 63 Squamous cell 63 Anticalins R 63 carcinoma HCC 63 anionic backbone 63 peptidic 63 bacterial parasitic 63 recombinant antibodies 63 IgG4 63 Kinoid 63 dyslipidemias 63 myelomas 63 histological subtype 63 hypophosphatasia 63 protein misfolding diseases 63 diabetic kidney 63 intracranial hemorrhage ICH 63 monocytic 63 virulence genes 63 JAK2 inhibitor 63 selective kinase inhibitor 63 histologies 63 proliferative retinopathy 62 preferentially bind 62 grade serous ovarian 62 drug ISA# 62 prion strains 62 non nucleoside HCV 62 proprietary BiTE ® 62 hematologic disorders 62 urothelial cancer 62 immunodeficiencies 62 Epothilone D 62 antiangiogenic activity 62 hormonal abnormalities 62 MOG #-# 62 reproductive abnormalities 62 hemagglutination inhibition HAI 62 tumor metastases 62 latent tuberculosis TB 62 malaria parasite Plasmodium falciparum 62 NPHP 62 ara C 62 ovarian endometrial 62 protein kinase inhibitor 62 gamma globin gene 62 mediated autoimmune diseases 62 malignant pancreatic 62 myeloproliferative neoplasms 62 BEXXAR Therapeutic Regimen 62 mutated p# 62 MAGE A3 ASCI 62 diabetic retinopathy DR 62 Valproic acid 62 LHRH antagonists 62 serous ovarian cancer 62 glycosylation profile 62 transcriptomics proteomics 62 Human papillomavirus 62 castrate resistant 62 Solazed TM 62 GERD migraine headaches 62 sorafenib tablets 62 Aganocide 62 AGHD 62 efaproxiral 62 inhibiting tumor 62 histologic subtypes 62 refractory Hodgkin 62 vaginal candidiasis 62 Tasigna prolongs 62 neuro developmental disorders 62 histocompatibility 62 breast cancer subtypes 62 bronchodilatory 62 circulating endothelial cells 62 INS# [001] 62 gp# protein [002] 62 antitumor effect 62 infectious diseases autoimmune diseases 62 nucleotide analogs 62 PI3K/Akt pathway inhibitor 62 galiximab 62 chronic periodontitis 62 systemic juvenile idiopathic 62 V#F mutation 62 Omacetaxine 62 HepDirect prodrug 62 myopathies 62 virus AAV 62 interferon lambda 62 RRM1 62 Granulocyte Colony Stimulating Factor 62 CXCL5 62 Glioblastoma multiforme 62 radiolabeled antibodies 62 Hepatocytes 62 antiviral cytokines 62 spontaneously regress 62 NSCLC tumors 62 bronchial epithelial cells 62 degenerative neurological diseases 62 busulfan 62 monoclonal antibody conjugated 62 alkylating agent 62 Janus Kinase 62 chemotherapeutic treatments 62 antibody mediated 62 oxacillin 62 haematological 62 hamartomas 62 Zalypsis 62 grade cervical dysplasia 62 gefitinib Iressa 62 pretransplant 62 Bayer HealthCare Onyx Pharmaceuticals 62 tumors GIST 62 pemphigus vulgaris 62 monogenic 62 prostate cancer CaP 62 serogroup B 62 mAbs 62 tumor histology 62 2 methoxyestradiol 62 upregulating 62 thalassemia sickle cell 62 HBV replication 62 Endometrial cancer 62 M# rationally 62 refractory gout 62 intra abdominal infections 62 vitamin D receptors 62 Chronic HCV 62 CYP#A# CYP#D# 62 Crucell genetically engineered 62 missense mutations 62 either acutely decompensated 62 selective antagonists 62 epigenetic markers 62 haematopoietic stem cell 62 atypical hemolytic uremic syndrome 62 TRAIL receptor antibodies 62 potent inducer 62 HeFH 62 pulmonary metastasis 62 PEGylated interferon 62 parthenolide 62 CD# CEA 62 antiangiogenic agents 62 membranous nephritis 62 neuropsychiatric diseases 62 Xenopus embryos 62 interferon alpha IFN 62 peptibody 62 glycosylated 62 iron chelators 62 fungal bacterial 62 nodal metastasis 62 Uterine cancer 62 clinically evaluable 62 rxRNA 62 tubulin inhibitor 62 ovarian pancreatic 62 Zoraxel TM 62 Immune responses 62 capsular polysaccharide 62 synovial fibroblasts 62 CCR5 mAb 62 BMPR2 62 Vidaza azacitidine 62 Opportunistic infections 62 recombinant spider silk 62 NS5B polymerase 62 PORxin TM platforms 62 myeloproliferative disorders 62 VEGF inhibitors 62 S. aureus colonization 62 Immunohistochemical staining 62 HBeAg negative 62 PLX STROKE targeting 62 SOD2 gene 62 anti CD3 62 trial evaluating PRX# 62 pleiotropic 62 systemically administered 62 #q# deletion 62 M. pneumoniae 62 vesicular stomatitis virus 62 CTAP# 62 O. volvulus 62 liver metastasis 62 Angiotensin converting enzyme 62 #S rRNA gene 62 davunetide intranasal AL 62 neuropathic pain spasticity 62 peptide conjugated 62 potent cytotoxic 62 Albuferon TM 62 Histone deacetylase 62 Macrolide 62 T1c 62 acute leukemias 62 epilepsy Parkinson disease 62 Mesenchymal 62 Panzem 62 leukemia ALL 62 hepatitis C viral infection 62 Virulizin ® 62 coagulation disorders 62 metastatic renal 62 HGS ETR2 62 potent suppressor 62 chlamydial infections 62 FUSILEV enhances 62 immunotoxin 62 Staphylococcus epidermidis 62 chromosomal rearrangement 62 T1DM 62 sarcoma melanoma 62 1 diabetes T1D 62 containing abacavir 62 anti secretory 62 neurotrophic 62 beta lactamases 62 onset diabetes mellitus 62 murine leukemia virus 62 Fragile X gene 62 C5aR 62 constitutively expressed 62 iPS derived 62 Candida infections 62 neoplastic cells 62 IgG1 62 bone marrow stromal cells 62 lymphoid cells 62 Selzentry Celsentri 62 metastatic gastric 62 refractory acute myeloid 62 predictive biomarkers 62 NF kB pathway 62 investigational therapies 62 mechanistic studies 62 Synovial sarcoma 62 tumor xenografts 62 oral ghrelin agonist 62 eccrine 62 telomerase inhibitor 62 intracellular signal transduction 62 BRAF kinase 62 hematological tumors 62 inhibits VEGF 62 colorectal adenocarcinoma 62 metabolizing enzyme 62 malaria parasite genome 62 NS5b 62 herpesviruses 62 MYCN amplification 62 plexiform 62 MenACWY 62 rhIGFBP 3 62 sequence homology 62 Protein Kinase C 62 Solazed 62 vascular occlusive diseases 62 Circulating tumor cells 62 miRNA biomarkers 62 lintuzumab SGN 62 induced anemia 62 mimetics 62 factor TNF 62 BPH benign prostatic 62 MTP inhibitor 62 BRAF V#E mutation 62 lymphoma myeloma 62 malignant lymphoma 62 fungus Cryptococcus neoformans 62 mucinous 62 Epigenomics proprietary 62 heparanase 62 smoldering multiple myeloma 62 hyaluronidase enzyme 62 S. aureus isolates 62 Annamycin 62 Chronic myeloid leukemia 62 gamma tocotrienol 62 psoriasis rheumatoid arthritis 62 overt nephropathy 62 treating sarcoma testicular 62 non adjuvanted vaccines 62 topical anti infectives 62 Soy isoflavones 62 oncolytic viruses 62 Entamoeba histolytica 62 Exelixis compounds 62 ENMD # 62 pan HDAC inhibitor 62 microRNA assays 62 pulmonary metastases 62 asthma rheumatoid arthritis 62 mutant KRAS 62 tRNA synthetases 62 Kit CD# positive 62 #T# tumor 62 HIF biology 62 transfusion syndrome 62 Achieves Primary Endpoint 62 primary hyperparathyroidism 62 neurite outgrowth 62 Azacitidine 62 Naive Patients 62 parasitemia 62 oral picoplatin 62 synthase TS 62 periodontal tissues 61 adeno associated viruses 61 serum biomarkers 61 CYP#A# enzyme 61 TransVax ™ 61 cathepsins 61 BCR ABL inhibitors 61 Corynebacterium 61 imatinib Gleevec ® 61 tests miRview TM 61 dasatinib Sprycel 61 endocrine dysfunction 61 trastuzumab DM1 T DM1 61 Plasmodium vivax 61 colorectal carcinoma 61 neovascularisation 61 Chlamydia psittaci 61 Fibroblast 61 Monoclonal antibody 61 EBV infection 61 Propionibacterium 61 Acute myeloid leukemia AML 61 HQK 61 chromosomal anomalies 61 synthetic lethality 61 echinocandins 61 TB bacilli 61 CD# expressing 61 candidate CRLX# 61 Locked Nucleic Acid LNA 61 non hodgkin lymphoma 61 pre cancerous actinic 61 Beta catenin pathway 61 biliary tract cancer 61 antiangiogenic agent 61 tumoral 61 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 61 intracellular bacteria 61 Aspergillus nidulans 61 transplantation HCT 61 drug zotarolimus 61 leukemia myeloma 61 malignant neoplasm 61 CCR9 antagonist 61 mycobacterial 61 CDH1 61 NSAID induced GI 61 Medullary thyroid cancer 61 liposome formulation 61 suppresses tumor 61 colon carcinoma 61 hepatorenal syndrome 61 methylation markers 61 fibrotic disease 61 Enterococcus faecium 61 including eniluracil ADH 61 adenoviral 61 cyclin E 61 small molecule thrombopoietin 61 caspofungin 61 metastatic pancreatic 61 Acute myeloid leukemia 61 neuroblastoma tumors 61 peroxisome 61 benzimidazole 61 seminomas 61 androgen dependent 61 potent inhibitors 61 urogenital infections 61 Recombinant interferon alpha 61 inhaled bronchodilators 61 cSSSIs 61 secretory diarrhea 61 neuronal dysfunction 61 Panzem NCD 61 arterial calcification 61 CYP#D# gene 61 elacytarabine 61 nucleotide variations 61 molecularly targeted therapies 61 Staphylococcus aureus infections 61 vascular disrupting agents 61 HepaMate 61 Camptothecin 61 IMiDs ® compound 61 ATC ovarian cancer 61 S/GSK# 61 susceptibility loci 61 KRAS mutations occur 61 Shark cartilage 61 extramedullary 61 genomic proteomic 61 acadesine 61 R sorafenib tablets 61 Cryptococcus neoformans 61 TNF alpha selectively neutralizing 61 CDK inhibitor 61 FOLOTYN ® 61 oncogenic transformation 61 5 HT1A receptor 61 Hepatocellular Carcinoma HCC 61 bacterium Mycobacterium tuberculosis 61 System IPSS 61 ErbB1 61 lymphocytic 61 breast pancreatic 61 metastatic GIST 61 acid phosphatase PAP 61 Eg5 61 sickle cell cystic fibrosis 61 HCV replication 61 systemic RNAi therapeutic 61 Bcr Abl mutations 61 DG# compounds targeting 61 deCODE AF TM 61 GIST tumors 61 biliary tract 61 Vidaza R 61 Squamous cell carcinomas 61 CINQUIL 61 Atopic eczema 61 interferon beta 1a infertility 61 PI3K inhibitors 61 motor neuron diseases 61 epithelial tissues 61 RAF kinase VEGFR 61 Glioblastomas 61 Carcinoid tumors 61 acute myeloid 61 treat chronic sinusitis 61 p# deficient 61 progressive neurodegenerative disorder 61 endometriosis ovarian cysts 61 JAK2 kinase 61 IAP inhibitor 61 immune modulators 61 bacterium Neisseria meningitidis 61 probiotic supplementation 61 osteoprotegerin 61 prognostic indicators 61 favorable pharmacokinetic 61 GMX# 61 chitinase 61 immunological responses 61 chemo resistant 61 muscle dystrophies 61 pluripotent embryonic 61 imatinib resistant 61 receptor blocker 61 antibody MAb 61 prostanoid 61 Hurthle cell 61 steroid refractory 61 testicular germ cell 61 Induced pluripotent stem cells 61 novel peptide therapeutics 61 syngeneic 61 monoclonal antibody MAb 61 LNP formulations 61 hormonally responsive 61 tumor antigen 61 Nilotinib 61 demyelinating diseases 61 erlotinib Tarceva ® 61 IMiDs 61 Zysolin TM 61 Acute lymphoblastic leukemia 61 biologic pathways 61 basal bolus regimen 61 nonviral 61 Curaxin CBLC# 61 neuropsychiatric disorder 61 Aviptadil 61 benign moles 61 Lung transplantation 61 Jhdm2a 61 commercialize deforolimus 61 mutant BRAF 61 mycobacterium tuberculosis 61 lung epithelium 61 nucleotide analogue 61 HepDirect R 61 neuro degenerative diseases 61 fibroma 61 acute promyelocytic leukemia APL 61 esophageal gastric 61 oral talactoferrin 61 Janus kinase 61 CRF1 receptor 61 CYP#A# substrate 61 Poly ICLC 61 cardio metabolic diseases 61 genetic determinants 61 immunomodulatory properties 61 severe hypersensitivity reactions 61 medulloblastoma tumors 61 KRAS mutated 61 recurrent metastatic 61 next generation URAT1 61 glutamic acid decarboxylase 61 bone marrow lymph nodes 61 enzyme cofactor 61 cytotoxin 61 polymerase inhibitors 61 antiproliferative effects 61 forodesine 61 PhG alpha 1 61 CYP #A# 61 granzyme B 61 methicillin sensitive 61 TLR8 agonist 61 tumor subtype 61 combination antiretroviral therapy 61 hormonally sensitive 61 lysosomal storage disease 61 IMA# 61 taxane resistant 61 euthymic patients 61 urologic diseases 61 serologic tests 61 TLR9 agonists 61 mutated KRAS gene 61 γ secretase 61 PORxin TM 61 Sezary syndrome 61 cardiometabolic disorders